KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Novartis Ag (NVS) Other Accumulated Expenses (2016 - 2023)

Historic Other Accumulated Expenses for Novartis Ag (NVS) over the last 16 years, with Q1 2024 value amounting to -$23.0 million.

  • Novartis Ag's Other Accumulated Expenses fell 36000.0% to -$23.0 million in Q1 2024 from the same period last year, while for Mar 2024 it was -$23.0 million, marking a year-over-year decrease of 36000.0%. This contributed to the annual value of $516.0 million for FY2023, which is 3827.75% down from last year.
  • Per Novartis Ag's latest filing, its Other Accumulated Expenses stood at -$23.0 million for Q1 2024, which was down 36000.0% from $516.0 million recorded in Q4 2023.
  • Novartis Ag's Other Accumulated Expenses' 5-year high stood at $836.0 million during Q4 2022, with a 5-year trough of -$113.0 million in Q3 2021.
  • Over the past 5 years, Novartis Ag's median Other Accumulated Expenses value was $137.0 million (recorded in 2021), while the average stood at $306.3 million.
  • Per our database at Business Quant, Novartis Ag's Other Accumulated Expenses soared by 46371.68% in 2022 and then tumbled by 36000.0% in 2024.
  • Novartis Ag's Other Accumulated Expenses (Quarter) stood at $749.0 million in 2020, then dropped by 17.36% to $619.0 million in 2021, then soared by 35.06% to $836.0 million in 2022, then tumbled by 38.28% to $516.0 million in 2023, then crashed by 104.46% to -$23.0 million in 2024.
  • Its Other Accumulated Expenses was -$23.0 million in Q1 2024, compared to $516.0 million in Q4 2023 and -$5.0 million in Q1 2023.